<DOC>
	<DOCNO>NCT01567800</DOCNO>
	<brief_summary>The purpose study look low level oxygen ( hypoxia ) prostate cancer use special x-ray test call positron emission tomography ( PET ) scan . Hypoxia may effect prostate cancer grow respond treatment like radiotherapy chemotherapy . The use PET scan measure hypoxia may better simpler method use previously .</brief_summary>
	<brief_title>Prostate Hypoxia FAZA</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Age = &gt; 18 year Histologic diagnosis adenocarcinoma prostate Bulky intermediate risk , high risk metastatic prostate cancer Bulky intermediate risk : cT12 &gt; 50 % diagnostic biopsy core contain cancer Gleason 6 7 prostate specific antigen ( PSA ) &gt; 10 ≤20 OR High risk : cT12 Gleason score ≥8 ; cT12 PSA &gt; 20 ; cT3 OR N+ and/or M1 disease OR Newly diagnose hormonerefractory prostate cancer Intention treat use radiotherapy +/ concurrent adjuvant hormonal therapy Intention treat radiotherapy , hormonal therapy , systemic treatment prostate cancer , combination accord Princess Margaret Genitourinary Site policy . Previous concurrent anticancer therapy PET FAZA target lesion allow Ability provide write informed consent participate study Inability lie supine 60 minute Patients take drug disulfiram ( Antabuse ) Contraindications MRI : applicable case PET FAZA target lesion identify prostate gland . Patients target lesion anatomic site undergo MR imaging . Patients weigh &gt; 136 kg</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Procedure/Surgery : 18F-Fluoroazomycin Arabinoside ( 18F-FAZA )</keyword>
</DOC>